6. パーキンソン病 Parkinson disease Clinical trials / Disease details


臨床試験数 : 2,307 薬物数 : 2,007 - (DrugBank : 349) / 標的遺伝子数 : 188 - 標的パスウェイ数 : 199

  
3 trials found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT05258071
(ClinicalTrials.gov)
June 15, 202210/2/2022A Clinical Study Evaluating Efficacy of Pirepemat on Falls Frequency in Patients With Parkinson's Disease (PD)A Randomised, Placebo-controlled, Multicentre Phase IIb Study Evaluating the Efficacy of Pirepemat on Falls Frequency in Patients With Parkinson's DiseaseParkinson DiseaseDrug: Pirepemat;Drug: PlaceboIntegrative Research Laboratories ABNULLRecruiting55 Years85 YearsAll165Phase 2France;Germany;Poland;Spain;Sweden
2EUCTR2019-002627-16-ES
(EUCTR)
31/03/202231/03/2022A study for evaluation of the efficacy of pirepemat on falls frequency in patients with Parkinson’s diseaseA randomised, placebo-controlled, multicentre phase IIb study evaluating the efficacy of pirepemat on falls frequency in patients with Parkinson’s disease Parkinson’s disease
MedDRA version: 20.0;Level: PT;Classification code 10061536;Term: Parkinson's disease;System Organ Class: 10029205 - Nervous system disorders;Therapeutic area: Diseases [C] - Nervous System Diseases [C10]
Product Name: Pirepemat, 50 mg
Product Code: IRL752
INN or Proposed INN: Pirepemat
Other descriptive name: Pirepemat x fumarate
Product Name: Pirepemat, 100 mg
Product Code: IRL752
INN or Proposed INN: Pirepemat
Other descriptive name: Pirepemat x fumarate
Integrative Research Laboratories Sweden AB (IRLAB)NULLAuthorised-recruitment may be ongoing or finishedFemale: yes
Male: yes
165Phase 2France;Poland;Spain;Germany;Sweden
3EUCTR2019-002627-16-PL
(EUCTR)
21/02/202211/01/2022A study for evaluation of the efficacy of pirepemat on falls frequency in patients with Parkinson’s diseaseA randomised, placebo-controlled, multicentre phase IIb study evaluating the efficacy of pirepemat on falls frequency in patients with Parkinson’s disease Parkinson’s disease
MedDRA version: 20.0;Level: PT;Classification code 10061536;Term: Parkinson's disease;System Organ Class: 10029205 - Nervous system disorders;Therapeutic area: Diseases [C] - Nervous System Diseases [C10]
Product Name: Pirepemat, 50 mg
Product Code: IRL752
INN or Proposed INN: Pirepemat
Other descriptive name: Pirepemat x fumarate
Product Name: Pirepemat, 100 mg
Product Code: IRL752
INN or Proposed INN: Pirepemat
Other descriptive name: Pirepemat x fumarate
Integrative Research Laboratories Sweden AB (IRLAB)NULLAuthorised-recruitment may be ongoing or finishedFemale: yes
Male: yes
165Phase 2France;Spain;Poland;Germany;Netherlands;Sweden